Innovation for Health - 15-16 April 2021
Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Els Beirnaert

CEO, Aelin Therapeutics

Els Beirnaert, PhD and CEO of Aelin Therapeutics, brings along 19 years of experience in drug development, venture and business development. Previously she was one of the start-up pioneers of Ablynx a company established in 2001 focused on biological therapeutics. She was leading multidisciplinary project teams and translating several drug development projects from discovery to clinical development (Phase 1 and 2). Since 2010, she was Head of New Ventures at VIB responsible for the establishment of multiple start-up companies in life sciences. She served in the board of directors of Confo Therapeutics, Q-Biologicals and Multiplicom. Dr. Beirnaert obtained a Master in Biotechnology at the University of Ghent and a PhD in Biochemistry at the Institute of Tropical medicine (University of Antwerp).
Jan van de Winkel
Genmab
Eline Vrijland-van Beest
Hybridize Therapeutics

Carmen van Vilsteren
Topsector Life Science & Health

Tim Van Hauwermeiren 
argenx

Antoon van Oosterhout
Imyse SA
Willem Mulder
TU/E
Jolanda M. de Vries
Radboudumc
Yvette van Kooyk
Amsterdam UMC
Ronald Plasterk
Frame Cancer Therapeutics
Paul WG Elbers
Amsterdam UMC
Prof. Dr. Ing. Ron A.M. Fouchier
Erasmus MC
Sponsors & Partners 2021
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Main Virtual Conference sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Powered by
Hyphen Projects
© 2020 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.
By continuing to use this site, you consent to our use of cookies. For more information, read: www.innovationforhealth.nl/privacy-policy